SAL-0140

N/A

Report date: 2026/02/10 20:00:22
NME

Base Information

Drug NameSAL-0140
Drug Alias NameSAL0140SAL-0140
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCytochrome P450 11B2 inhibitors
TargetsCytochrome P450 11B2
Therapy Area/IndicationsHyperaldosteronismHypertensionRenal Insufficiency, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesShenzhen Salubris Pharmaceuticals Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShenzhen Salubris Pharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsHyperaldosteronismHypertensionRenal Insufficiency, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A